These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16750352)

  • 21. Microbial growth tests in anti-neoplastic injectable solutions.
    Paris I; Paci A; Rey JB; Bourget P
    J Oncol Pharm Pract; 2005 Mar; 11(1):7-12. PubMed ID: 16460598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A centralized Pharmacy Unit for cytotoxic drugs in accordance with Italian legislation.
    Baldo P; Bertola A; Basaglia G; Moneghini M; Sorio R; Zibardi E; Lazzarini R; De Paoli P
    J Eval Clin Pract; 2007 Apr; 13(2):265-71. PubMed ID: 17378874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality-control plan for intravenous admixture programs. I: Visual inspection of solutions and environmental testing.
    Morris BG; Avis KE
    Am J Hosp Pharm; 1980 Feb; 37(2):189-95. PubMed ID: 7361790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirtieth report.
    World Health Organ Tech Rep Ser; 1987; 748():1-50. PubMed ID: 3111103
    [No Abstract]   [Full Text] [Related]  

  • 25. [Improving the quality of compounded medicines through self-assessment: proof of concept].
    Wauters K; Fierens C; Corthout J; Sarre S; Saevels J
    J Pharm Belg; 2014 Jun; (2):26-33. PubMed ID: 25055453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability issues of parenteral chemotherapy drugs.
    de Lemos ML; Hamata L
    J Oncol Pharm Pract; 2007 Mar; 13(1):27-31. PubMed ID: 17621564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spectrophotometric analysis of products manufactured in hospital pharmacy.
    Am J Hosp Pharm; 1968 Jul; 25(7):383-5. PubMed ID: 5696160
    [No Abstract]   [Full Text] [Related]  

  • 28. Standards vs opinions.
    Allen LV
    Int J Pharm Compd; 2014; 18(2):92. PubMed ID: 24881110
    [No Abstract]   [Full Text] [Related]  

  • 29. [Scientific rationale for the replacement of an in vivo bioassay for protein drugs with a physico-chemical assay].
    Hayakawa T
    Eisei Shikenjo Hokoku; 1994; (112):202-3. PubMed ID: 8854933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality specifications for peptide drugs: a regulatory-pharmaceutical approach.
    Vergote V; Burvenich C; Van de Wiele C; De Spiegeleer B
    J Pept Sci; 2009 Nov; 15(11):697-710. PubMed ID: 19750489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Formulation and stability study of sucred solutions for a clinical trial in neonates].
    Senis-Loiseau C; Vaillant C; Markiewicz-Massy A; Torck M; Thielmans B
    Ann Pharm Fr; 2003 Nov; 61(6):425-30. PubMed ID: 14639195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative determination of anti-tumor agent bis(4-fluorobenzyl)trisulfide, fluorapacin and its pharmaceutical preparation by high-performance liquid chromatography.
    Bao Y; He Y; Xu X; Mo X; Xu X; Wang X; An H
    J Pharm Biomed Anal; 2008 Jan; 46(1):206-10. PubMed ID: 17964749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The handling of antineoplastic drugs in a major cancer center.
    Hoffman DM
    Hosp Pharm; 1980 Jun; 15(6):302-4. PubMed ID: 10247269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time and cost comparison of four methods of filling drug manufacturers' piggyback bottles.
    Anderson ER; Soares MS
    Am J Hosp Pharm; 1985 May; 42(5):1083-6. PubMed ID: 4003420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of instrumental colour measurement in development and quality control of drugs and pharmaceutical excipients.
    Subert J; Cizmárik J
    Pharmazie; 2008 May; 63(5):331-6. PubMed ID: 18557414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multistate outbreak of Serratia marcescens bloodstream infection associated with contaminated intravenous magnesium sulfate from a compounding pharmacy.
    Sunenshine RH; Tan ET; Terashita DM; Jensen BJ; Kacica MA; Sickbert-Bennett EE; Noble-Wang JA; Palmieri MJ; Bopp DJ; Jernigan DB; Kazakova S; Bresnitz EA; Tan CG; McDonald LC
    Clin Infect Dis; 2007 Sep; 45(5):527-33. PubMed ID: 17682984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug safety, drug quality, drug analysis.
    Görög S
    J Pharm Biomed Anal; 2008 Sep; 48(2):247-53. PubMed ID: 18082992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality control begins before drugs are purchased.
    Lamy PP; Flack HL
    Hospitals; 1967 Oct; 41(19):123-6. PubMed ID: 6052047
    [No Abstract]   [Full Text] [Related]  

  • 39. The risks of substitution of therapeutic modalities by cheaper and sometimes less effective agents.
    Brook I
    Arch Intern Med; 1990 Mar; 150(3):688-9. PubMed ID: 2310291
    [No Abstract]   [Full Text] [Related]  

  • 40. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.